HMGB1 and neoplasm: Specifically, lethal radiation damage triggers the release of HMGB-1 from tumor cells, leading to complex immune responses.(42–44) Previous studies have shown that the activation of anti-tumor immune responses occurs when HMGB-1 release surpasses a specific threshold.